Rocket Pharmaceuticals Inc (RCKT) Stock Price, Quote & News

Company Profile

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a late-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases in the United States. It develops vivo adeno-associated viral (AAV) programs, which include programs for Danon disease (DD), a multi-organ lysosomal-associated disorder leading to early death due to heart failure (RP-A501), which is in Phase 2 trial; Plakophilin-2 Arrhythmogenic Cardiomyopathy (PKP2-ACM), an inher...

Industry: Biotechnology

Sector: Healthcare

Phone: 609 659 8001

Website: www.rocketpharma.com

Address:

9 Cedarbrook Drive, Cranbury, United States

DinoMcnuggets Aug. 27 at 2:47 PM

$RCKT Market is valuing the pipeline at 100M. Danon disease alone is a 2B dollar opportunity. This doesn’t include Kresladi and the rest of the pipeline. They have 0 debt. No warrants. No covenants. Cash until late 2027. The balance sheet is at clean as it gets, but the company is priced for complete failure of every molecule. If you want to talk about a biotech company that is so extremely undervalued, this is it.

0 · Reply

reez007 Aug. 27 at 2:22 PM

$RCKT lol we are in penny flipper hell

0 · Reply

Stephanovich7654568 Aug. 26 at 11:31 PM

$RCKT Buyout on it's way

0 · Reply

nupasani Aug. 26 at 10:54 PM

$RCKT surprising news didn’t drop this even lower…CFO resigning should have been a 20% drop today maybe tomorrow??

1 · Reply

JoeBio Aug. 26 at 8:10 PM

$RCKT close but no cigar. Perhaps tomorrow

0 · Reply

DinoMcnuggets Aug. 26 at 3:35 PM

$RCKT Every single company in the last 7 years that the previously resigning CFO has worked for was bought out. Mirati, Arena, and Alexion all were bought out. Before that he worked for Regeneron. Guy seems to have the magic touch.

1 · Reply

Stephanovich7654568 Aug. 26 at 2:15 PM

$RCKT I told you a while ago. We are on a verge of a buyout. This is why the edge fund is changing the principale head. When you put close to 100 millions dollars in a company, you wanna make sure that your hands are on the steering wheel.

1 · Reply

Chasse_patate Aug. 26 at 2:09 PM

$RCKT $3 million a year and leaving before he really started. Not a good sign.

1 · Reply

DinoMcnuggets Aug. 26 at 1:58 PM

$RCKT Added a chunk.

0 · Reply

JoeBio Aug. 26 at 1:43 PM

$RCKT Im'a buyer waiting at 3.33!

1 · Reply

Gene Therapy Trial Can Restart After Patient Death, FDA Says. The Sector Remains Depressed.

Aug 20, 2025, 9:31 AM EDT - 7 days ago

FDA Lifts Rocket Pharmaceuticals Study Hold For Rare Disease Gene Therapy

Aug 20, 2025, 7:09 AM EDT - 7 days ago

US FDA lifts clinical hold on Rocket Pharmaceuticals' gene therapy trial

Aug 20, 2025, 7:00 AM EDT - 7 days ago

Rocket Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on the Pivotal Phase 2 Trial of RP-A501 for the Treatment of Danon Disease

Aug 8, 2025, 2:16 PM EDT - 18 days ago

DEADLINE NEXT WEEK: Berger Montague Advises Rocket Pharmaceuticals (NASDAQ: RCKT) Investors to Contact the Firm Before August 11, 2025

Aug 7, 2025, 4:00 PM EDT - 19 days ago

Rocket Pharmaceuticals Reports Second Quarter 2025 Financial Results and Highlights Recent Progress

Jul 30, 2025, 6:29 PM EDT - 27 days ago

SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 30, 2025, 11:07 AM EDT - 4 weeks ago

What's Going On With Sarepta, Capricor And Other Gene Therapy Stocks On Wednesday?

CAPR SRPT CABA NGNE NTLA QURE

Jul 29, 2025, 10:26 AM EDT - 4 weeks ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 25, 2025, 3:02 PM EDT - 4 weeks ago

Rocket Refocuses Pipeline As Gene Therapy Sentiment Sours

Jul 24, 2025, 4:02 PM EDT - 4 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Pharmaceuticals, Inc. Lawsuit – RCKT

Jul 24, 2025, 7:00 AM EDT - 4 weeks ago

Rocket Pharmaceuticals Announces Strategic Corporate Reorganization and Pipeline Prioritization of Cardiovascular Programs

Jul 17, 2025, 7:00 AM EDT - 5 weeks ago

Rocket Pharmaceuticals Receives FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for RP-A601 Gene Therapy for PKP2-Arrhythmogenic Cardiomyopathy

Jul 11, 2025, 10:25 AM EDT - 6 weeks ago

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Rocket Pharmaceuticals

Jul 9, 2025, 5:16 PM EDT - 6 weeks ago

Berger Montague PC Investigates Rocket Pharmaceuticals (RCKT) Over Safety Disclosures and Stock Drop

Jul 7, 2025, 9:00 AM EDT - 7 weeks ago

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of August 11, 2025 in Rocket Lawsuit - RCKT

Jun 30, 2025, 7:00 AM EDT - 2 months ago

Rocket Pharmaceuticals Announces FDA IND Clearance of RP-A701 for the Treatment of BAG3-associated Dilated Cardiomyopathy

Jun 12, 2025, 10:00 AM EDT - 2 months ago

Rocket Pharmaceuticals, Inc. (RCKT) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Jun 11, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Rocket Pharmaceuticals, Inc. (RCKT) Shareholders to Inquire about Securities Investigation

Jun 10, 2025, 10:00 AM EDT - 2 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Rocket Pharmaceuticals, Inc. (RCKT) And Encourages Shareholders to Connect

DinoMcnuggets Aug. 27 at 2:47 PM

0 · Reply

reez007 Aug. 27 at 2:22 PM

$RCKT lol we are in penny flipper hell

0 · Reply

Stephanovich7654568 Aug. 26 at 11:31 PM

$RCKT Buyout on it's way

0 · Reply

nupasani Aug. 26 at 10:54 PM

$RCKT surprising news didn’t drop this even lower…CFO resigning should have been a 20% drop today maybe tomorrow??

1 · Reply

JoeBio Aug. 26 at 8:10 PM

$RCKT close but no cigar. Perhaps tomorrow

0 · Reply

DinoMcnuggets Aug. 26 at 3:35 PM

1 · Reply

Stephanovich7654568 Aug. 26 at 2:15 PM

1 · Reply

Chasse_patate Aug. 26 at 2:09 PM

$RCKT $3 million a year and leaving before he really started. Not a good sign.

1 · Reply

DinoMcnuggets Aug. 26 at 1:58 PM

$RCKT Added a chunk.

0 · Reply

JoeBio Aug. 26 at 1:43 PM

$RCKT Im'a buyer waiting at 3.33!

1 · Reply

AStrokeOfLuck Aug. 26 at 12:33 PM

$RCKT Probably explains some weakness recently despite FDA hold being lifted - CFO resigns https://rocketpharmaceuticals.gcs-web.com/static-files/a0acb6ea-0ed5-48f2-aa01-aaf6fb36b9d7

1 · Reply

healthcareguru Aug. 26 at 12:24 PM

$RCKT wait…so things are “getter better” and the CFO resigns?! Not a good look! Guess he didn’t want 50%+ dilution on his watch. 👎

0 · Reply

Nierka1 Aug. 26 at 12:07 PM

$RCKT something happening today!!!!

0 · Reply

stockstelegraph Aug. 25 at 2:48 PM

🚨 Analyst Upgrades to Watch (Aug 23) 🚨 🔥 $RCKT +175% Upside | Target $10 | Jason Zemansky (80% accuracy) ⚡ $CRVW +96% Upside | Target $180 | Kevin Dede (66% accuracy) 📈 $IQ +32% Upside | Target $3.32 | Zhijing Liu (64% accuracy) 💻 $HPE +24% Upside | Target $32 | Meta Marshall (73% accuracy) Strong calls backed by reliable analysts — worth watching 👀 #StocksToWatch #AnalystUpgrades #Trading #StockMarket #Investing via @stockstelegraph

0 · Reply

Newtimmy Aug. 25 at 10:48 AM

$RCKT LFG

0 · Reply

sumon89 Aug. 25 at 8:18 AM

$RCKT they have 96.3% institutional ownership, so they constantly control the narrative of all the news . The EU move was a good one, but the news was painted as a bad one . There still is time to loud up on Shares if you believe in this company. The institutions will keep it here for a while longer 🤞

0 · Reply

RedToGreenMan Aug. 24 at 11:47 PM

$RCKT was $8 six months ago and $6.85 when the “hold”dropped it. I think we dip for a minute, but ought to recover nicely 🤷🤔

0 · Reply

RonBarkly Aug. 24 at 11:30 PM

$RCKT

1 · Reply

nupasani Aug. 24 at 11:08 PM

$RCKT opens at 3.15 tomorrow

2 · Reply

JL_TradeZ Aug. 24 at 11:13 AM

WEEKEND RECAP #9 Called $RCKT from 3.30–3.45 with breakout over 3.60 and it ripped right through both 3.80 and 4.00 targets. Fresh FDA clearance flipped the May crash, 55M float with 20% short interest gave real squeeze fuel, and volume came in 5x average while holding VWAP. Textbook biotech reversal setup that played out clean 🎯

0 · Reply

Stephanovich7654568 Aug. 23 at 2:47 PM

$RCKT We had close to $100 millions trading in a day,this week, so we are on a roller. Nobody put that amount of money without beeing reassured. ❤️❤️❤️❤️❤️

0 · Reply

abasol64 Aug. 23 at 9:57 AM

$RCKT long run can be rewarding

0 · Reply

Market Cap	381.98M
Revenue (ttm)	0.00
Net Income (ttm)	-258.75M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.00

Volume	4,800,500
Avg Vol	4,610,852
Day's Range	N/A - N/A
Shares Out	107.90M
Stochastic %K	42%
Beta	0.65
Analysts	Sell
Price Target	$8.60